Takayuki Goto

12PUBLICATIONS
52CO-AUTHORS
Molecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 30, 2026
Primary site- and metastasis-directed therapies in patients with metastatic prostate cancer: A narrative review.

|May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency.

|Jan 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Jan 16, 2026
Association between preoperative interruption of antiplatelet therapy and postoperative thrombotic risk after minimally invasive surgery for abdominopelvic cancer in patients treated with P2Y12 inhibitors.

Masashi Kubota, Satomi Yoshida, Takayuki Goto

|Oct 18, 2025
Adverse Events in Testicular Cancer Survivors Using EORTC QLQ-TC26: A Multi-Institutional, Cross-Sectional Study in Japan.

Takuro Goto, Shinichi Yamashita, Kenichi Kakimoto

|Sep 10, 2025
Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensity.

Takashi Ogata, Rihito Aizawa, Hiroyasu Abe

Pageof 2

Frequent Collaborators

4 joint publications

Takayuki Sumiyoshi

4 joint publications

Takashi Kobayashi

2 joint publications

Shinichi Yamashita

2 joint publications

Takeshi Kishida